Media Coverage

Article featured in WholeFoods magazine

Sabinsa announced that Curcumin C3 Reduct has been approved by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list.

Read More...


Article featured in Nutraceutical Business Review

This approval allows introduction and commercialization of C3 Reduct, most active metabolite of curcumin, in food and supplements in Brazil.

Read More...


Article featured in Nutra Ingredients USA

Natural ingredient supplier Sabinsa announced this week that The Brazilian Health Regulatory Agency (ANVISA) has green-lighted its Curcumin C3 Reduct as health ingredient in the country.

Read More...


Article featured in Nutrition Insight

This week in nutrition news, Sabinsa gained authorization from Brazil’s National Health Surveillance Agency (ANVISA) for Curcumin C3 Reduct to enter the country’s market.

Read More...


Article featured in Nutritional Outlook

Curcumin C3 Reduct has earned approval by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list, which allows the product to be introduced and commercialized in food and supplements in Brazil.

Read More...


    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US